相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study
Tse-Min Lu et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Role of Asymmetrical Dimethylarginine in Inflammation-Induced Endothelial Dysfunction in Human Atherosclerosis
Charalambos Antoniades et al.
HYPERTENSION (2011)
Endothelial function as a functional expression of cardiovascular risk factors
Martin K. Reriani et al.
BIOMARKERS IN MEDICINE (2010)
Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus
Maike Anderssohn et al.
DIABETES & VASCULAR DISEASE RESEARCH (2010)
The Metabolic Syndrome and Cardiovascular Risk A Systematic Review and Meta-Analysis
Salvatore Mottillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Carol Kilkenny et al.
PLOS BIOLOGY (2010)
Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice
Daniel W. Nuno et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria
Latika Sibal et al.
CARDIOVASCULAR DIABETOLOGY (2009)
Vascular endothelium in atherosclerosis
Anca V. Sima et al.
CELL AND TISSUE RESEARCH (2009)
Oxidative stress as a mediator of cardiovascular disease
Maqsood M. Elahi et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2009)
Impairment of endothelium-dependent ACh-induced relaxation in aorta of diabetic db/db mice -: possible dysfunction of receptor and/or receptor-G protein coupling
Tomohiro Miike et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
Sulfaphenazole treatment restores endothelium-dependent vasodilation in diabetic mice
Shahrzad Elmi et al.
VASCULAR PHARMACOLOGY (2008)
Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism
David E. L. Wilcken et al.
MOLECULAR GENETICS AND METABOLISM (2007)
The flavonoid Silibinin decreases glucose-6-phosphate hydrolysis in perifused rat Hepatocytes by an inhibitory effect on glucose-6-phosphatase
Bruno Guigas et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2007)
Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss
T McLaughlin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover
EB Marliss et al.
DIABETOLOGIA (2006)
Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure
PWB Nanayakkara et al.
KIDNEY INTERNATIONAL (2005)
Protective effects of silybin on human umbilical vein endothelial cell injury induced by H2O2 in vitro
YK Wang et al.
VASCULAR PHARMACOLOGY (2005)
The human liver clears both asymmetric and symmetric dimethylarginine
MPC Siroen et al.
HEPATOLOGY (2005)
Polyphenols and prevention of cardiovascular diseases
C Manach et al.
CURRENT OPINION IN LIPIDOLOGY (2005)
Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries
GJL Lagaud et al.
JOURNAL OF VASCULAR RESEARCH (2001)
Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes
A Fard et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
